Onxeo SA
F:C4X
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Onxeo SA
F:C4X
|
FR |
|
U
|
UTStarcom Holdings Corp
BMV:UTSI
|
CN |
|
B
|
Boston Omaha Corp
XMUN:42S
|
US |
|
M
|
Modelon AB (publ)
STO:MODEL B
|
SE |
|
Observe Medical ASA
F:OM50
|
NO |
|
Cybertrust Japan Co Ltd
F:5U2
|
JP |
|
B
|
BlueRush Inc
OTC:BTVRF
|
CA |
|
Imaflex Inc
F:6YS
|
CA |
|
4DS Memory Ltd
OTC:FRDSF
|
AU |
|
S
|
Shihlin Development Co Ltd
TPEX:5324
|
TW |
|
Deltic Energy PLC
F:7RC0
|
UK |
|
B
|
Beijing Media Corp Ltd
XBER:BME
|
CN |
|
Global Wellness Strategies Inc
F:O3X
|
CA |
|
Nordic Mining ASA
F:7NM
|
NO |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is C4X's stock price target?
Not Available
C4X does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Onxeo SA?
Projected CAGR
702%
Over the last 6 years, the compound annual growth rate for Revenue has been -17%. The projected CAGR for the next 2 years is 702%.